Nicotinamide n-methyltransferase (nnmt) and 1-methylnicotinamide (mna) in experimental hepatitis induced by concanavalin a in the mouse

Pharmacological Reports

Volumn 62, Issue 3, 2010, Pages 483-493

  Sternak, Magdalena ^a   Khomich, Tamara I ^b   Jakubowski, Andrzej ^a   Szafarz, Małgorzata ^a   Szczepański, Wojciech ^a   Białas, Magdalena ^a   Stojak, Marta ^a   Szymura Oleksiak, Joanna ^a   Chłopicki, Stefan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Institute of Pharmacology and Biochemistry   (Poland)

Author keywords

1 methylnicotinamide; BALB c mice; Concanavalin A; Hepatits; Nicotinamide N methyltransferase

Indexed keywords

1 METHYL 4(1H) OXO 5 PYRIDINECARBOXAMIDE; 1 METHYL 6 OXONICOTINAMIDE; 1 METHYLNICOTINAMIDE; ALANINE AMINOTRANSFERASE; CONCANAVALIN A; DRUG METABOLITE; GAMMA INTERFERON; NICOTINAMIDE METHYLTRANSFERASE; PROSTACYCLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; N(1)-METHYLNICOTINAMIDE; NICOTINAMIDE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HEPATITIS; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; T LYMPHOCYTE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL HEPATITIS; BAGG ALBINO MOUSE; BLOOD; ENZYMOLOGY; GERMFREE ANIMAL; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY;

ALANINE TRANSAMINASE; ANIMALS; CONCANAVALIN A; FEMALE; HEPATITIS, ANIMAL; INTERFERON-GAMMA; LIVER; MICE; MICE, INBRED BALB C; NIACINAMIDE; NICOTINAMIDE N-METHYLTRANSFERASE; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954841794     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70304-2     Document Type: Article

References (47)

1. Aksoy S, Szumlanski CL, Weinshilboum RM: Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem, 1994, 269, 14835-14840.
2. Aoyama K, Matsubara K, Okada K, Fukushima S, Shimizu K, Yamaguchi S, Uezono T et al.: N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test. J Neural Transm, 2000, 107, 985-995.
3. Barlow GB, Sutton JL, Wilkinson AW: Metabolism of nicotinic acid in children with burns and scalds. Clin Chim Acta, 1977, 75, 337-342.
4. Bartuś M, Łomnicka M, Kostogrys RB, Kaźmierczak P, Watała C, Słomińska EM, Smoleński RT et al.: 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacol Rep, 2008, 60, 127-138.
5. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72, 248-254.
6. Bryniarski K, Biedron R, Jakubowski A, Chlopicki S, Marcinkiewicz J: Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. Eur J Pharmacol, 2008, 578, 332-338.
7. Brzozowski T, Konturek PC, Chlopicki S, Sliwowski Z, Pawlik M, Ptak-Belowska A, Kwiecień S et al.: Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves. J Pharmacol Exp Ther, 2008, 326, 105-116.
8. Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartuś M, Łomnicka M, Adamus J, Ge{ogonek}bicki J: 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/ prostacyclin pathway. Br J Pharmacol, 2007, 152, 230-239.
9. Chu CJ, Hsiao CC, Wang TF, Chan CY, Lee FY, Chang FY, Chen YC et al.: Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure. World J Gastroenterol, 2005, 11, 232-236.
10. Clarke S, Banfield K: S-adenosylmethionine-dependent methyltrasferases. In: Homocysteine in health and disease. Eds. Carmel R. Jacobsen DW, Cambridge University Press, Cambridge, 2001, 63-78.
11. Cuomo R, Dattilo M, Pumpo R, Capuano G, Boselli L, Budillon G: Nicotinamide methylation in patients with cirrhosis. J Hepatol, 1994, 20, 138-142.
12. Cuomo R, Pumpo R, Sarnelli G, Capuano G, Budillon G: Nicotinamide methylation and hepatic energy reserve: a study by liver perfusion in vitro. J Hepatol, 1995, 23, 465-470.
13. Dong H, Toyoda N, Yoneyama H, Kurachi M, Kasahara T, Kobayashi Y, Inadera H et al.: Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system. Biochem Biophys Res Commun, 2002, 298, 675-686.
14. Dostalek M, Hardy KD, Milne GL, Morrow JD, Chen C, Gonzalez FJ, Gu J et al.: Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotidedependent protective systems. J Biol Chem, 2008, 283, 17147-17157.
15. Egashira Y, Isagawa A, Komine T, Yamada E, Ohta T, Shibata K, Sanada H: Tryptophan-niacin metabolism in liver cirrhosis rat caused by carbon tetrachloride. J Nutr Sci Vitaminol (Tokyo), 1999, 45, 459-469.
16. Egashira Y, Komine T, Ohta T, Shibata K, Sanada H: Change of tryptophan-niacin metabolism in D-galactosamineinduced liver injury in rat. J Nutr Sci Vitaminol (Tokyo), 1997,43,233-239.
17. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G: Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology, 1995,21,1901-98.
18. Gedik E, Girgin S, Obay BD, Ozturk H, Ozturk H, Buyukbayram H: Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats. Acta Cir Bras, 2009, 24, 226-232.
19. Gryglewski RJ: Prostacyclin among prostanoids. Pharmacol Rep, 2008, 60, 3-11.
20. Hoshino J, Kuhne U, Kroger H: Enhancement of DNA synthesis and cell proliferation by 1-methylnicotinamide in rat liver cells in culture: implication for its in vivo role. Biochem Biophys Res Commun, 1982, 105, 1446-1452.
21. Hoshino J, Schluter U, Kroger H: Nicotinamide methylation and its relation to NAD synthesis in rat liver tissue culture. Biochemical basis for the physiological activities of 1-methylnicotinamide. Biochim Biophys Acta, 1984, 801,250-258.
22. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW: The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res, 2004,14, 491-499.
23. Kim J, Hong SJ, Lim EK, Yu YS, Kim SW, Roh JH, Do IG et al.: Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. J Exp Clin Cancer Res, 2009, 28-20.
24. Kusters S, Gantner F, Kunstle G, Tiegs G: Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology, 1996, 111, 462-471.
25. Lim BH, Cho BI, Kim YN, Kim JW, Park ST, Lee CW: Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med, 2006, 38, 455-465.
26. Mateuszuk L, Khomich TI, Słomińska E, Gajda M, Wójcik L, Łomnicka M, Gwóźdź P, Chłopicki S: Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacol Rep, 2009, 61, 76-85.
27. Matsubara K, Aoyama K, Suno M, Awaya T: N-methylation underlying Parkinson's disease. Neurotoxicol Teratol, 2002, 24, 593-598.
28. Nanji AA, Khwaja S, Sadrzadeh SM: Decreased prostacyclin production by liver non-parenchymal cells precedes liver injury in experimental alcoholic liver disease. Life Sci, 1994, 54,455-461.
29. Ohta S, Nakamuta M, Fukushima M, Kohjima M, Kotoh K, Enjoji M, Nawata H: Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice. Liver Int, 2005, 25, 1061-1068.
30. Okamura A, Ohmura Y, Islam MM, Tagawa M, Horitsu K, Moriyama Y, Fujimura S: Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma. Jpn J Cancer Res, 1998, 89, 649-656.
31. Pumpo R, Sarnelli G, Spinella A, Budillon G, Cuomo R: The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5carboxamide production. Am J Gastroenterol, 2001, 96, 1183-1187.
32. Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R: Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis, 2008, 204, 412-417.
33. Rini J, Szumlanski C, Guerciolini R, Weinshilboum RM: Human liver nicotinamide N-methyltransferase: ionpairing radiochemical assay, biochemical properties and individual variation. Clin Chim Acta, 1990, 186, 359-374.
34. Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, Engel AM, Schneidinger B et al.: Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin Cancer Res, 2005, 11, 6550-6557.
35. Sano A, Takimoto N, Takitani S: Fluorometric assay of nicotinamide methyltransferase with a new substrate, 4-methylnicotinamide. Chem Pharm Bull (Tokyo), 1989, 37, 3330-3332.
36. Sartini D, Santarelli A, Rossi V, Goteri G, Rubini C, Ciavarella D, Lo Muzio L, Emanuelli M: Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol Med, 2007, 13, 415-421.
37. Sass G, Heinlein S, Agli A, Bang R, Schumann J, Tiegs G: Cytokine expression in three mouse models of experimental hepatitis. Cytokine, 2002, 19, 115-120.
38. Seifert R, Hoshino J, Kroger H: Nicotinamide methylation. Tissue distribution, developmental and neoplastic changes. Biochim Biophys Acta, 1984, 801, 259-264.
39. Souto JC, Blanco-Vaca F, Soria JM, Buil A, Almasy L, Ordońez-Llanos J, Martín-Campos JM et al.: A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet, 2005, 76, 925-933.
40. Stanulovic M, Chaykin S: Metabolic origins of the pyridones of N 1-methylnicotinamide in man and rat. Arch Biochem Biophys, 1971, 145, 35-42.
41. Szafarz M, Lomnicka M, Sternak M, Chlopicki S, Szymura-Oleksiak J: Simultaneous determination of nicotinic acid and its four metabolites in rat plasma using high performance liquid chromatography with tandem mass spectrometric detection (LC/MS/MS), J Chromatogr B, 2010, 895-902.
42. Tiegs G, Hentschel J, Wendel A: A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest, 1992, 90, 196-203.
43. Tomida M, Mikami I, Takeuchi S, Nishimura H, Akiyama H: Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. J Cancer Res Clin Oncol, 2009, 135, 1223-1229.
44. Tomida M, Ohtake H, Yokota T, Kobayashi Y, Kurosumi M: Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells. J Cancer Res Clin Oncol, 2008, 134, 551-559.
45. WataŁa C, Kaźmierczak P, Dobaczewski M, Przygodzki T, Bartuś M, Łomnicka M, Słomińska EM et al.: Anti diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats. Pharmacol Rep, 2009, 61, 86-98. 46.
46. Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D: Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyl-transferase as novel regulators of cell migration. Oncogene, 2008, 27, 6679-6689.
47. Yan L, Otterness DM, Craddock TL, Weinshilboum RM: Mouse liver nicotinamide N-methyltransferase: cDNA cloning, expression, and nucleotide sequence polymorphisms. Biochem Pharmacol, 1997, 54, 1139-1149.